AMED AMEDISYS INC revenue, earnings and financials
For the quarter ended June 30, 2025, AMEDISYS INC reported revenue of $622M (up 5.2% from a year earlier), net income of $28.1M and diluted EPS of $0.84; over the last four quarters revenue was $2.40B and net income $85.6M; for the fiscal year ended December 2024 revenue was $2.35B, up 5.0% on the year before.
AMED annual revenue and earnings
- Fiscal year ended Dec 2024: revenue $2.35B, gross profit n/a, operating income $94.5M, net income $43.2M (margin 1.8%), EPS $1.31
- Fiscal year ended Dec 2023: revenue $2.24B, gross profit n/a, operating income $156M, net income −$9.75M (margin -0.4%), EPS −$0.30
- Fiscal year ended Dec 2022: revenue $2.22B, gross profit n/a, operating income $181M, net income $119M (margin 5.3%), EPS $3.63
- Fiscal year ended Dec 2021: revenue n/a, gross profit n/a, operating income $252M, net income $209M (margin n/a), EPS $6.34
AMED quarterly revenue and earnings
- Quarter ended Jun 30, 2025: revenue $622M (up 5.2% year over year), net income $28.1M, EPS $0.84
- Quarter ended Mar 31, 2025: revenue $595M (up 4.1% year over year), net income $61.0M, EPS $1.84
- Quarter ended Dec 31, 2024 (from the annual report): revenue $598M (up 4.8% year over year), net income −$20.4M, EPS −$0.62
- Quarter ended Sep 30, 2024: revenue $588M (up 5.7% year over year), net income $16.9M, EPS $0.51
- Quarter ended Jun 30, 2024: revenue $591M (up 6.9% year over year), net income $32.3M, EPS $0.98
- Quarter ended Mar 31, 2024: revenue $571M (up 2.7% year over year), net income $14.4M, EPS $0.44
- Quarter ended Dec 31, 2023 (from the annual report): revenue $571M, net income $19.3M, EPS $0.60
- Quarter ended Sep 30, 2023: revenue $556M, net income $26.0M, EPS $0.79
- Quarter ended Jun 30, 2023: revenue $553M, net income −$80.3M, EPS −$2.46
- Quarter ended Mar 31, 2023: revenue $556M, net income $25.2M, EPS $0.77
- Quarter ended Dec 31, 2022 (from the annual report): revenue n/a, net income $31.7M, EPS $0.96
- Quarter ended Sep 30, 2022: revenue n/a, net income $25.6M, EPS $0.79
- Quarter ended Jun 30, 2022: revenue n/a, net income $29.6M, EPS $0.91
- Quarter ended Mar 31, 2022: revenue n/a, net income $31.7M, EPS $0.97
- Quarter ended Dec 31, 2021 (from the annual report): revenue n/a, net income $34.0M, EPS $1.04
- Quarter ended Sep 30, 2021: revenue n/a, net income $45.0M, EPS $1.37
- Quarter ended Jun 30, 2021: revenue n/a, net income $80.1M, EPS $2.43
- Quarter ended Mar 31, 2021: revenue n/a, net income $49.9M, EPS $1.50
AMED cash flow, buybacks and dividends
- Fiscal year ended Dec 2024: operating cash flow $222M, share buybacks $0
- Fiscal year ended Dec 2023: operating cash flow $137M, share buybacks $0
- Fiscal year ended Dec 2022: operating cash flow $133M, share buybacks $17.4M
- Fiscal year ended Dec 2021: operating cash flow $189M, share buybacks $99.9M
AMED balance sheet
- Jun 30, 2025: cash $337M, total assets $2.22B, total liabilities $940M, shareholders' equity $1.23B, long-term debt $326M
- Mar 31, 2025: cash $285M, total assets $2.18B, total liabilities $940M, shareholders' equity $1.20B, long-term debt $333M
- Dec 31, 2024: cash $303M, total assets $2.14B, total liabilities $959M, shareholders' equity $1.13B, long-term debt $339M
- Sep 30, 2024: cash $245M, total assets $2.14B, total liabilities $939M, shareholders' equity $1.15B, long-term debt $344M
- Jun 30, 2024: cash $150M, total assets $2.12B, total liabilities $938M, shareholders' equity $1.13B, long-term debt $351M
- Mar 31, 2024: cash $108M, total assets $2.09B, total liabilities $947M, shareholders' equity $1.09B, long-term debt $356M
- Dec 31, 2023: cash $126M, total assets $2.06B, total liabilities $940M, shareholders' equity $1.07B, long-term debt $362M
- Sep 30, 2023: cash $78.1M, total assets $2.03B, total liabilities $934M, shareholders' equity $1.04B, long-term debt $367M
What is AMED's revenue?
AMEDISYS INC reported $2.40B of revenue over its last four quarters, through June 30, 2025.
Is AMED profitable?
Yes. AMEDISYS INC earned $85.6M over the last four quarters.
What is AMED's EPS?
Diluted earnings per share over the last four quarters were $2.57; $0.84 in the latest quarter.